1. Home
  2. JF vs FEMY Comparison

JF vs FEMY Comparison

Compare JF & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JF

J and Friends Holdings Limited American Depositary Shares

N/A

Current Price

$0.96

Market Cap

19.1M

Sector

N/A

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$3.96

Market Cap

21.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JF
FEMY
Founded
2012
2004
Country
China
United States
Employees
30
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
21.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JF
FEMY
Price
$0.96
$3.96
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
9.3K
48.8K
Earning Date
04-24-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.71
EPS
N/A
N/A
Revenue
N/A
$2,293,313.00
Revenue This Year
N/A
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.77
52 Week Low
$0.89
$0.29
52 Week High
$1.19
$6.29

Technical Indicators

Market Signals
Indicator
JF
FEMY
Relative Strength Index (RSI) 37.63 60.93
Support Level $0.91 $0.47
Resistance Level $1.02 $6.29
Average True Range (ATR) 0.06 0.41
MACD -0.01 -0.13
Stochastic Oscillator 6.74 35.94

Price Performance

Historical Comparison
JF
FEMY

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: